Can physician adherence to treatment guidelines improve patient survival? A population-based analysis of non-small cell lung cancer (NSCLC) in Taiwan

Taiwan Journal of Public Health

Volumn 29, Issue 2, 2010, Pages 118-130

  Chen, His Chieh ^a   Su, Hui Fang ^a   Li, Chung Y I ^a   Lai, Mei Shu ^b   Hsieh, P I Ching ^a  

^a NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Guideline adherence; Non small cell lung cancer (nsclc); One year survival; Taiwan cancer data base

Indexed keywords

EID: 77954477459     PISSN: 10232141     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. WHO. WHO Statistical Information System (WHOSIS). Available at: http://www.who.int/whosis/en/index.html Accessed March 18, 2008.
3. D'Addario G, Felip E. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008;19(Suppl 2): ii39-40.
4. National Comprehensive Cancer Network. Clinical practice guideline in oncology. Available at: http://www.nccn.org/professionals/physician-gls/PDF/nscl pdf. Accessed March 13,2008.
5. Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd Edition). Chest 2007;132(suppl):234S-42S.
6. Robinson LA, Ruckdeschel JC, Wagner H, Stevens CW. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(suppl):243S-65S.
7. Jett JR, Schild SE, Keith RL, Kesler KA. Treatment of non-small cell lung cancer, stage HIB: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(suppl):266S-76S.
8. Socinski MA, Crowell R, Hensing TE, et al. Treatment of non-small cell lung cancer, stage IV - ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(suppl):277S-89S.
9. Minter RM, Spengler KK, Topping DP, Flug R, Copeland EM, Lind DS. Institutional validation of breast cancer treatment guidelines. J Surg Res 2001;100:106-9.
10. Hébert-Croteau N, Brisson J, Latreille J, Rivard M, Abdelaziz N, Martin G. Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer. J Clin Oncol 2004;22:3685-93.
11. Yun YH, Park SM, Noh DY, et al. Trends in breast cancer treatment in Korea and impact of compliance with consensus recommendations on survival. Breast Cancer Res Treat 2007;106:245-53.
12. Cheng SH, Wang J, Lin JL, et al. Adherence to quality indicators and survival in patients with breast cancer. Med Care 2009;47:217-25.
13. Birim Ö, Kappetein AP, van Klaveren R, Bogers AMC. Prognostic factors in non-small cell lung cancer surgery. Eur J Surg Oncol 2006;32:12-23.
14. Bach PB, Cramer LD, Schräg D, Downey RJ, Gelfand SE, Begg CB. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med 2001;345:181-8.
15. Hannan EL, Radzyner M, Rubin D, Dougherty J, Brennan MF. The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery 2002;131:6-15.
16. Strand TE, Rostad H, Moller B, Norstein J. Survival after resection for primary lung cancer: a population based study of 3211 resected patients. Thorax 2006;61:710-5.
17. Lien YC, Huang MT, Lin HC. Association between surgeon and hospital volume and in-hospital fatalities after lung cancer resections: the experience of an Asian country. Ann Thorac Surg 2007;83:1837-43.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
19. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
20. Klabunde C, Warren JL, Legier J. Assessing comorbidity using claims data: an overview. Med Care 2002;40(suppl):IV26-35.
21. Farray D, Mirkovic N, Albain KS. Multimodality therapy for stage III non-small-cell lung cancer. J Clin Oncol 2005;23:3257-69.
22. Burdett S, Stewart LA, Rydzewska L. A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer. J Thorac Oncol 2006;1:611-21.
23. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framewouk for improvement. JAMA 1999;282:1458-65.
24. Sinuff T, Cook D, Giacomini M, Heyland D, Dodek P. Facilitating clinician adherence to guidelines in the intensive care unit: a multicenter, qualitative study. Crit Care Med 2007;35:2083-9.
25. Sjetne IS, Veenstra M, Stavem K. The effect of hospital size and teaching status on patient: a multilevel analysis. Med Care 2007;45:252-8.